StockData
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. (OVID) stock

OVIDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$2.22−0.18 (-7.50%)

Close on Nov 17, 2026Market cap $433.56MP/E –Yield –

Ovid Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Ovid Therapeutics's EV/EBITDA was 0.0× on Apr 29, 2022.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2022Apr 29, 20220.0×−0.1
2021Dec 31, 20210.1×–

More Ovid Therapeutics figures

See a number that looks wrong?